Screening compound: C19H23ClN4O2S (F042-1054)

Screening compound: C<sub>19</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>2</sub>S (F042-1054)
Screening compound: C<sub>19</sub>H<sub>23</sub>ClN<sub>4</sub>O<sub>2</sub>S (F042-1054) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C19H23ClN4O2S (F042-1054)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F042-1054

Molecular Formula

C19H23ClN4O2S (C19 H23 ClN4 O2 S)

Compound Name

2-(2-{[(4-chlorophenyl)carbamoyl]amino}-1,3-thiazol-4-yl)-N-(cyclohexylmethyl)acetamide

IUPAC name

2-(2-{[(4-chlorophenyl)carbamoyl]amino}-13-thiazol-4-yl)-N-(cyclohexylmethyl)acetamide

SMILES

O=C(Cc1csc(NC(Nc(cc2)ccc2Cl)=O)n1)NCC1CCCCC1

InChI

InChI=1S/C19H23ClN4O2S/c20-14-6-8-15(9-7-14)22-18(26)24-19-23-16(12-27-19)10-17(25)21-11-13-4-2-1-3-5-13/h6-9,12-13H,1-5,10-11H2,(H,21,25)(H2,22,23,24,26)

InChI Key

HZDZFNZDXBARKX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08535093

C19H23ClN4O2S (F042-1054) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with C19H23ClN4O2S (F042-1054) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C19H23ClN4O2S (F042-1054)?
Check Price and Availability of C19H23ClN4O2S (F042-1054), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C19H23ClN4O2S (F042-1054) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C19H23ClN4O2S (F042-1054)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C19H23ClN4O2S (F042-1054)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C19H23ClN4O2S (F042-1054) available by request